Nevertheless, little is known about the relationship between p53 protein expression, as assayed through immunohistochemical staining, and the presence of TP53 mutations, detected via sequencing, in patients with advanced EGFR-mutated NSCLC. Here, TP53 is linked to non-small cell lung carcinoma.